# Histone Acetylation: Mechanisms, Functions, and Study Methods

## Introduction to Histone Acetylation

### What is Histone Acetylation?

Histone acetylation is a post-translational modification (PTM) in which an acetyl group (–COCH₃) is covalently attached to specific lysine residues on the N-terminal tails of histone proteins. These histones—primarily H2A, H2B, H3, and H4—form the protein core around which DNA wraps to create the [histone nucleosome](/knowledge/molecular-biology/histone-nucleosome), the fundamental repeating unit of chromatin. The modification is reversible and dynamically regulated by two opposing enzyme families: histone acetyltransferases (HATs), which add acetyl groups, and histone deacetylases (HDACs), which remove them.

The addition of an acetyl group to a lysine residue neutralizes the lysine's positive charge at physiological pH. This charge neutralization weakens the electrostatic interaction between the histone tail and the negatively charged phosphate backbone of DNA, promoting a more open chromatin conformation. Because chromatin compaction directly influences the accessibility of DNA to [transcription factors](/knowledge/molecular-biology/transcription-factor) and RNA polymerase, histone acetylation is a central mechanism of transcriptional regulation.

### Why It Matters in Gene Regulation

Histone acetylation is one of the best-characterized components of the [histone code](/knowledge/molecular-biology/histone-code)—the hypothesis that specific combinations of histone modifications dictate particular chromatin states and functional outcomes. Acetylation is overwhelmingly associated with actively transcribed genes. Genome-wide studies have shown that acetylation marks, particularly at histone H3 lysine 27 (H3K27ac) and H3 lysine 9 (H3K9ac), are enriched at promoter regions and enhancers of actively expressed genes.

The importance of histone acetylation extends beyond simple transcriptional activation. It participates in diverse processes including DNA repair, replication, alternative splicing, and cellular differentiation. Misregulation of acetylation is a hallmark of many cancers and neurological disorders, making the enzymes that control this modification major therapeutic targets. Understanding the mechanisms, functions, and methods used to study histone acetylation is therefore essential for any student of molecular biology.

## The Molecular Mechanism of Histone Acetylation

### Histone Acetyltransferases (HATs)

Histone acetyltransferases catalyze the transfer of an acetyl group from acetyl-coenzyme A (acetyl-CoA) to the ε-amino group of a lysine residue on a histone tail. HATs are broadly classified into two families based on their subcellular localization and function.

**Type A HATs** are nuclear enzymes that acetylate chromatin-associated histones and function in transcriptional regulation. The major Type A HAT families include:

- **GNAT family** (Gcn5-related N-acetyltransferases): Includes Gcn5 and PCAF (p300/CBP-associated factor). These enzymes preferentially acetylate H3 lysines, particularly H3K9 and H3K14.
- **MYST family** (named after MOZ, Ybf2/Sas3, Sas2, and Tip60): Includes Tip60, MOF, MOZ, and HBO1. These HATs show substrate specificity for H4K16 and other sites.
- **p300/CBP family**: p300 and its close homolog CBP (CREB-binding protein) are large, multidomain proteins that acetylate all four core histones and numerous non-histone proteins. They are considered global transcriptional coactivators.

**Type B HATs** are cytoplasmic enzymes that acetylate newly synthesized histones before their incorporation into chromatin. The prototypical Type B HAT is Hat1, which acetylates H4K5 and H4K12 during histone synthesis in the cytoplasm.

HATs typically function as components of large multiprotein complexes. For example, Gcn5 exists within the SAGA (Spt-Ada-Gcn5-acetyltransferase) complex, which contains more than 20 subunits. These complexes target HATs to specific genomic loci through interactions with sequence-specific DNA-binding transcription factors, providing specificity to the acetylation process.

### Acetyl-CoA as the Acetyl Donor

Acetyl-CoA is the obligate acetyl donor for all histone acetylation reactions. The reaction proceeds as follows:

Lysine (on histone) + Acetyl-CoA → Nε-acetyllysine + CoA + H⁺

The high-energy thioester bond of acetyl-CoA makes the transfer thermodynamically favorable. The availability of acetyl-CoA links histone acetylation to cellular metabolism. Under conditions of high nutrient availability, acetyl-CoA levels rise, promoting global histone acetylation and increased transcriptional activity. Conversely, caloric restriction or metabolic stress reduces acetyl-CoA pools, leading to decreased acetylation and altered gene expression. This metabolic-epigenetic connection is an active area of research.

### The Role of Histone Tails

The N-terminal tails of histones—approximately 20–35 amino acids long—protrude from the nucleosome core and are the primary sites of acetylation. These tails are rich in basic residues (lysine and arginine) and are largely unstructured in solution, making them accessible to modifying enzymes. The tail regions are also sites for numerous other modifications, including methylation, phosphorylation, and ubiquitination, which can cross-talk with acetylation.

The [histone octamer](/knowledge/molecular-biology/histone-octamer) consists of two copies each of H2A, H2B, H3, and H4. The H3 and H4 tails are particularly important for inter-nucleosomal interactions that promote chromatin compaction. Acetylation of these tails disrupts these interactions, contributing to chromatin decondensation. The H4 tail, for instance, contacts the acidic patch of neighboring nucleosomes; acetylation of H4K16 specifically inhibits this interaction and is a critical regulator of higher-order chromatin folding.

## Types of Histone Acetylation

### Common Acetylation Sites

Acetylation can occur on multiple lysine residues across all four core histones. The most extensively studied sites include:

| Histone | Common Acetylation Sites | Associated Function |
|---------|-------------------------|---------------------|
| H3 | K9, K14, K18, K23, K27, K36, K56 | Transcriptional activation (K9, K14, K27), DNA repair (K56) |
| H4 | K5, K8, K12, K16 | Transcriptional activation, chromatin decondensation (K16) |
| H2A | K5, K7, K9, K13, K15 | Transcriptional activation, DNA damage response |
| H2B | K5, K11, K12, K15, K16, K20, K23, K24 | Transcriptional elongation, mRNA processing |

The nomenclature follows a standard convention: "H3K9ac" indicates acetylation of lysine 9 on histone H3. The number refers to the position of the lysine from the N-terminus of the mature protein (after removal of the initiator methionine).

### Specificity of HAT Enzymes

Different HATs show distinct substrate specificities, although there is considerable redundancy and overlap. For example:

- **Gcn5/PCAF**: Preferentially acetylate H3K9 and H3K14.
- **p300/CBP**: Broad specificity, acetylating multiple sites on H3 and H4, including H3K18, H3K27, H4K5, and H4K8.
- **Tip60**: Acetylates H4K5, H4K8, H4K12, and H4K16, as well as H2A.
- **MOF**: Highly specific for H4K16.
- **HBO1**: Acetylates H3K14 and H4K5/K8/K12, playing roles in DNA replication.

This specificity is determined by the structural architecture of the HAT catalytic domain and its interaction with flanking residues surrounding the target lysine. The bromodomain—a protein module that recognizes acetylated lysines—is present in many HATs and helps anchor the enzyme to already-acetylated chromatin, enabling processive acetylation of adjacent sites.

It is important to note that acetylation is not limited to a single lysine per histone tail. Multiple lysines can be acetylated simultaneously, and the term "mono-acetylation" refers to a single acetyl group on one lysine, not a single acetyl group per histone. There is no "di-" or "tri-acetylation" of a single lysine in the way that methylation can occur as mono-, di-, or tri-methylation. Each lysine can carry at most one acetyl group.

## Functional Consequences of Histone Acetylation

### Chromatin Relaxation and Transcription Activation

The primary biochemical consequence of histone acetylation is the neutralization of the positive charge on lysine residues. In its unmodified state, a lysine carries a +1 charge at physiological pH. This positive charge interacts electrostatically with the negatively charged phosphate backbone of DNA, contributing to tight DNA-histone contacts. Acetylation converts the lysine to Nε-acetyllysine, which is uncharged, eliminating this electrostatic interaction.

The charge neutralization has two major effects:

1. **Intra-nucleosomal effects**: Weakened histone-DNA contacts within a single nucleosome increase the accessibility of the DNA to transcription factors and other DNA-binding proteins.
2. **Inter-nucleosomal effects**: Reduced positive charge on histone tails diminishes their ability to bridge neighboring nucleosomes, preventing the formation of compact 30-nm fibers and higher-order chromatin structures.

The net result is a shift toward a more open, "euchromatic" chromatin state that is permissive for transcription. This is why histone acetylation is universally associated with active gene expression.

### Recruitment of Transcriptional Machinery

Beyond charge neutralization, acetylated lysines serve as docking sites for proteins containing bromodomains. The bromodomain is an approximately 110-amino-acid module that specifically recognizes acetylated lysine residues. Proteins containing bromodomains include:

- **Transcriptional coactivators**: Such as the SWI/SNF [chromatin remodeling](/knowledge/molecular-biology/chromatin-remodeling) complex (via its BRG1 and BRM subunits), which uses ATP hydrolysis to slide or evict nucleosomes.
- **General transcription factors**: TAF1 (TBP-associated factor 1), a subunit of TFIID, contains double bromodomains that recognize acetylated H4, helping recruit the basal transcription machinery to promoters.
- **Histone acetyltransferases themselves**: Many HATs contain bromodomains, allowing them to bind to their own acetylation products and spread acetylation along the gene.
- **BET family proteins**: BRD2, BRD3, BRD4, and BRDT bind acetylated histones and recruit the positive transcription elongation factor b (P-TEFb), which phosphorylates RNA polymerase II to promote transcriptional elongation.

The recognition of acetylated lysines by bromodomain-containing proteins constitutes a key readout mechanism of the [histone code](/knowledge/molecular-biology/histone-code). This protein-protein interaction is highly specific: different bromodomains show distinct preferences for particular acetylation sites, providing another layer of regulatory specificity.

## Histone Deacetylation and Its Role in Gene Silencing

### Histone Deacetylases (HDACs)

Histone deacetylases catalyze the removal of acetyl groups from lysine residues, reversing the effects of HATs and promoting chromatin compaction and transcriptional repression. HDACs are divided into four classes based on sequence homology and catalytic mechanism:

| Class | Members | Catalytic Mechanism | Localization |
|-------|---------|---------------------|--------------|
| Class I | HDAC1, HDAC2, HDAC3, HDAC8 | Zinc-dependent | Predominantly nuclear |
| Class IIa | HDAC4, HDAC5, HDAC7, HDAC9 | Zinc-dependent | Nuclear/cytoplasmic shuttling |
| Class IIb | HDAC6, HDAC10 | Zinc-dependent | Predominantly cytoplasmic |
| Class IV | HDAC11 | Zinc-dependent | Nuclear/cytoplasmic |
| Class III | SIRT1–SIRT7 | NAD⁺-dependent | Nuclear (SIRT1,6,7), cytoplasmic (SIRT2), mitochondrial (SIRT3–5) |

The Class III sirtuins are mechanistically distinct: they require NAD⁺ as a cofactor and transfer the acetyl group to ADP-ribose, producing O-acetyl-ADP-ribose and nicotinamide. This NAD⁺ dependence links sirtuin activity to cellular energy status.

Like HATs, HDACs function within multiprotein complexes. Class I HDACs are found in complexes such as Sin3, NuRD (nucleosome remodeling and deacetylase), and CoREST, which target them to specific genomic loci. HDACs are recruited to genes by sequence-specific transcriptional repressors, such as the nuclear hormone receptors in their unliganded state, and by DNA methylation-binding proteins like MeCP2.

The equilibrium between HAT and HDAC activity determines the steady-state acetylation level at any given locus. This balance is dynamic, with acetylation and deacetylation occurring on timescales of minutes to hours.

### HDAC Inhibitors and Their Applications

HDAC inhibitors (HDACi) are a class of compounds that block HDAC activity, leading to hyperacetylation of histones and altered gene expression. These compounds are classified by their chemical structure:

- **Hydroxamic acids**: Trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA/vorinostat)
- **Short-chain fatty acids**: Sodium butyrate, valproic acid
- **Benzamides**: Entinostat, mocetinostat
- **Cyclic peptides**: Romidepsin, trapoxin

HDAC inhibitors have emerged as promising anticancer agents. Vorinostat and romidepsin are FDA-approved for the treatment of cutaneous T-cell lymphoma. Their mechanism of action is complex: they reactivate silenced [tumor suppressor genes](/knowledge/molecular-biology/tumor-suppressor-gene), induce cell cycle arrest and apoptosis, and enhance the immunogenicity of cancer cells. However, because HDACs have numerous non-histone substrates (including p53, tubulin, and NF-κB), HDAC inhibitors have pleiotropic effects that are not fully understood.

Sodium butyrate, produced by gut microbiota through fermentation of dietary fiber, is a natural HDAC inhibitor. This has led to interest in the role of the microbiome in modulating host gene expression through [epigenetic mechanisms](/knowledge/molecular-biology/epigenetic-mechanisms).

## Methods to Study Histone Acetylation

### Chromatin Immunoprecipitation (ChIP)

Chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR) or high-throughput sequencing (ChIP-seq) is the gold standard for mapping histone acetylation at specific genomic loci or genome-wide. The procedure involves several steps:

1. **Crosslinking**: Cells are treated with formaldehyde (typically 1% final concentration) for 10 minutes at room temperature to covalently crosslink proteins to DNA.
2. **Quenching**: Glycine (0.125 M) is added to stop the crosslinking reaction.
3. **Cell lysis and sonication**: Cells are lysed, and chromatin is sheared by sonication to fragments of approximately 200–600 base pairs. This typically requires 10–20 cycles of 30 seconds on/30 seconds off at high power, with optimization needed for each cell type.
4. **Immunoprecipitation**: Sheared chromatin is incubated with an antibody specific for the acetylation mark of interest (e.g., anti-H3K27ac) coupled to protein A/G beads. Incubation is typically performed overnight at 4°C.
5. **Washing**: Beads are washed sequentially with low-salt, high-salt, LiCl, and TE buffers to remove non-specific binding.
6. **Elution and reverse crosslinking**: Bound chromatin is eluted (typically with 1% SDS in TE buffer), and crosslinks are reversed by heating at 65°C for 4–6 hours.
7. **DNA purification**: DNA is purified by phenol-chloroform extraction or column-based kits.
8. **Analysis**: Purified DNA is analyzed by qPCR (for specific loci) or by next-generation sequencing (for genome-wide profiling).

ChIP-seq requires 10–50 ng of immunoprecipitated DNA for library preparation. Data analysis involves peak calling to identify regions of enrichment relative to input or IgG controls.

### Antibody-Based Detection

Western blotting is a rapid method to assess global levels of specific acetylation marks. Histones are acid-extracted from cells (using 0.2 M H₂SO₄, followed by acetone precipitation) or isolated from nuclei, separated by SDS-PAGE on high-percentage gels (15% is typical for histones), and transferred to PVDF membranes. Membranes are probed with acetylation-specific antibodies (e.g., anti-H3K9ac, anti-H4K16ac) and detected by chemiluminescence.

Key considerations for Western blotting of histone modifications include:

- **Antibody specificity**: Acetylation-specific antibodies must be validated for cross-reactivity with unmodified histones and with other acetylation sites. Peptide competition assays are recommended.
- **Loading controls**: Total histone H3 or H4 antibodies are used as loading controls, as total histone levels are relatively constant.
- **Quantification**: Densitometry can provide semi-quantitative comparisons between samples.

[Immunofluorescence microscopy](/blog/guides/immunofluorescence-microscopy-controls-for-specific-and-reproducible-images) using acetylation-specific antibodies allows visualization of the spatial distribution of acetylation within the nucleus. This technique requires careful optimization of fixation and permeabilization conditions to preserve epitope accessibility.

### Mass Spectrometry for Global Profiling

Mass spectrometry (MS) provides an unbiased, comprehensive view of histone acetylation. The approach involves:

1. **Histone extraction and purification**: Histones are acid-extracted and separated by reverse-phase HPLC to isolate individual histone proteins.
2. **Chemical derivatization**: Histones are treated with propionic anhydride to block unmodified lysines, preventing trypsin from cleaving at these sites. This "propionylation" step is critical for generating peptides of analyzable size.
3. **Proteolytic digestion**: Propionylated histones are digested with trypsin, which now cleaves only at arginine residues.
4. **LC-MS/MS analysis**: Peptides are separated by liquid chromatography and analyzed by tandem mass spectrometry.
5. **Data analysis**: Software tools identify acetylated peptides and quantify the relative abundance of each modification state.

Mass spectrometry can identify novel acetylation sites, quantify the stoichiometry of modifications (the fraction of histone molecules carrying a specific mark), and reveal combinatorial modification patterns. However, it requires specialized equipment and expertise and is less accessible than antibody-based methods.

## Histone Acetylation in Development and Disease

### Role in Stem Cell Differentiation

Histone acetylation plays a critical role in cellular differentiation, where global changes in chromatin structure accompany the transition from pluripotency to lineage commitment. Embryonic stem cells (ESCs) are characterized by a hyperdynamic, open chromatin state with high levels of histone acetylation. As cells differentiate, specific genes are silenced or activated, and the acetylation landscape is remodeled accordingly.

Key observations include:

- **Pluripotency genes** (such as Oct4, Sox2, and Nanog) show high levels of H3K9ac and H3K27ac at their promoters in ESCs. Upon differentiation, these marks are lost, and the genes become silenced.
- **Lineage-specific genes** acquire acetylation marks at their promoters and enhancers as differentiation proceeds, correlating with their activation.
- **Enhancer regions** marked by H3K27ac (active enhancers) are established during differentiation and are predictive of cell identity.

The balance between HATs and HDACs is crucial for maintaining the differentiated state. HDAC inhibitors can partially revert differentiated cells to a more pluripotent state, and HDAC inhibitors are used to improve the efficiency of induced pluripotent stem cell (iPSC) generation.

### Aberrant Acetylation in Cancer

Cancer is characterized by widespread epigenetic dysregulation, and histone acetylation is frequently altered in malignant cells. Several mechanisms contribute:

- **Mutations in HATs**: The p300 and CBP genes are mutated or deleted in various cancers, including colorectal, gastric, and breast cancers. Loss of function leads to reduced acetylation of [tumor suppressor gene](/knowledge/molecular-biology/tumor-suppressor-gene) promoters and their silencing.
- **Translocations generating fusion proteins**: The MOZ and MORF genes (MYST family HATs) are involved in chromosomal translocations in acute myeloid leukemia, generating fusion proteins with aberrant acetyltransferase activity.
- **Overexpression of HDACs**: HDAC1, HDAC2, and HDAC3 are overexpressed in many solid tumors and hematological malignancies. This leads to deacetylation and silencing of tumor suppressor genes.
- **Altered acetylation at specific loci**: Genome-wide studies have identified specific genes with aberrant acetylation patterns in cancer, including silencing of tumor suppressors (e.g., p21, p53 targets) and activation of oncogenes.

The clinical relevance of these findings is underscored by the FDA approval of HDAC inhibitors for cancer treatment. Additionally, BET inhibitors (which block bromodomain recognition of acetylated lysines) are in clinical trials for various cancers, particularly those driven by MYC overexpression.

## Common Pitfalls and Misconceptions

### Acetylation vs. Methylation

Students frequently confuse histone acetylation with [histone methylation](/knowledge/molecular-biology/histone-methylation), but these modifications differ fundamentally:

| Feature | Acetylation | Methylation |
|---------|-------------|-------------|
| Added group | Acetyl (–COCH₃) | Methyl (–CH₃) |
| Effect on lysine charge | Neutralizes positive charge | Maintains positive charge |
| Enzymes that add | HATs | Histone methyltransferases (HMTs) |
| Enzymes that remove | HDACs, sirtuins | Histone demethylases (KDMs) |
| Functional association | Generally activation | Activation or repression, depending on site and degree |
| Maximum modifications per lysine | One | Three (mono-, di-, tri-) |

The functional consequences are also distinct. While acetylation is almost universally associated with transcriptional activation, methylation can be activating (e.g., H3K4me3) or repressive (e.g., H3K27me3) depending on the specific lysine and the degree of methylation.

### Not All Acetylation Activates Transcription

While histone acetylation is generally associated with active transcription, there are important exceptions:

- **H3K56ac**: This modification occurs on the globular domain of H3 (not the tail) and is primarily associated with DNA replication and repair, not transcription.
- **Acetylation at some enhancers**: Not all acetylated enhancers are active; some show "poised" states with acetylation but lack other activation marks.
- **Context-dependence**: The effect of acetylation depends on the genomic context, the specific lysine modified, and the combination with other modifications. Acetylation of H4K16, for example, has different effects depending on whether it occurs at promoters, enhancers, or gene bodies.

### Additional Common Errors

- **Assuming acetylation is permanent**: Acetylation is highly dynamic, with rapid turnover. The half-life of acetyl groups on histones ranges from minutes to hours.
- **Confusing HATs with HDACs**: HATs add acetyl groups; HDACs remove them. This is a common exam error.
- **Forgetting non-histone substrates**: HATs and HDACs also modify numerous non-histone proteins, including transcription factors (p53, NF-κB) and structural proteins (tubulin).
- **Overlooking the role of acetyl-CoA**: Histone acetylation is metabolically sensitive; acetyl-CoA availability directly influences acetylation levels.
- **Ignoring antibody limitations**: ChIP and Western blot results depend heavily on antibody quality and specificity. Validation is essential.

## Summary and Key Takeaways

Histone acetylation is a central [epigenetic modification](/knowledge/molecular-biology/epigenetic-modification) that regulates chromatin structure and gene expression. The addition of acetyl groups to lysine residues on histone tails by HATs neutralizes positive charge, loosens chromatin, and creates docking sites for bromodomain-containing proteins. The opposing action of HDACs reverses these effects, promoting chromatin compaction and gene silencing. The dynamic balance between HATs and HDACs is crucial for normal cellular function, and its disruption contributes to diseases such as cancer.

## Frequently Asked Questions

### What is the meaning of histone acetylation?

Histone acetylation is the covalent addition of an acetyl group (–COCH₃) to the ε-amino group of lysine residues on the N-terminal tails of histone proteins. This post-translational modification is catalyzed by histone acetyltransferases (HATs) using acetyl-CoA as the acetyl donor. Acetylation neutralizes the positive charge of lysine, weakening histone-DNA interactions and promoting a more open chromatin structure that is permissive for transcription.

### What are the steps of histone acetylation?

The process of histone acetylation involves several steps: (1) A HAT enzyme binds to its substrate—a lysine residue on a histone tail—within the context of chromatin; (2) The enzyme positions acetyl-CoA in its active site; (3) The acetyl group is transferred from acetyl-CoA to the ε-amino group of the target lysine, forming Nε-acetyllysine and releasing coenzyme A; (4) The modified histone may be recognized by bromodomain-containing proteins, which can recruit additional factors or further HATs to spread acetylation. The reverse reaction, deacetylation, is catalyzed by HDACs.

### What are the types of histone acetylation?

Histone acetylation is classified by the specific histone and lysine residue modified. Common types include H3K9ac, H3K14ac, H3K27ac, H4K5ac, H4K8ac, H4K12ac, and H4K16ac. Each site can carry at most one acetyl group per lysine (unlike methylation, which can be mono-, di-, or tri-). Different HATs show specificity for different sites, and the functional consequences vary by location.

### What is the function of histone acetylation?

The primary functions of histone acetylation are: (1) Neutralizing the positive charge of lysine residues, which weakens histone-DNA interactions and promotes chromatin decondensation; (2) Creating binding sites for bromodomain-containing proteins that recruit transcriptional machinery; (3) Marking active promoters and enhancers; (4) Participating in DNA repair and replication. Overall, histone acetylation is strongly associated with transcriptional activation.

### Can you give examples of histone acetylation?

Examples include: (1) H3K27ac marks active enhancers and promoters in mammalian cells; (2) H4K16ac is critical for chromatin decondensation on the X chromosome and is lost in many cancers; (3) H3K9ac is enriched at the promoters of actively transcribed genes; (4) H3K56ac occurs during DNA replication and is important for nucleosome assembly and genome stability.

### What is the process of histone acetylation?

The process begins with the recognition of the target lysine by a HAT enzyme. The HAT catalyzes the transfer of an acetyl group from acetyl-CoA to the lysine's ε-amino group. This reaction is reversible: HDACs remove the acetyl group, restoring the positive charge. The steady-state level of acetylation at any locus reflects the balance between HAT and HDAC activities, which are regulated by signaling pathways, [transcription factor](/knowledge/molecular-biology/transcription-factor) recruitment, and metabolic state.

### What is the overview of histone acetylation?

Histone acetylation is a dynamic, reversible post-translational modification of histone proteins that regulates chromatin structure and gene expression. It is added by HATs and removed by HDACs. Acetylation neutralizes lysine's positive charge, loosening chromatin and promoting transcription, and serves as a docking site for bromodomain-containing proteins. It plays critical roles in development, differentiation, and disease, and is a major therapeutic target in cancer.

## Key Takeaways

- Histone acetylation is the addition of acetyl groups to lysine residues on histone tails, catalyzed by HATs using acetyl-CoA as the donor.
- Acetylation neutralizes lysine's positive charge, weakening histone-DNA interactions and promoting open chromatin and transcriptional activation.
- Acetylated lysines serve as binding sites for bromodomain-containing proteins, which recruit transcriptional coactivators and remodeling complexes.
- HDACs reverse acetylation, promoting chromatin compaction and gene silencing; HDAC inhibitors are used as anticancer drugs.
- Histone acetylation is dynamic and metabolically sensitive, linking cellular energy status to gene expression.
- Common acetylation sites include H3K9, H3K14, H3K27, and H4K16, each with distinct functional roles.
- Key methods for studying acetylation include ChIP-seq, Western blotting with modification-specific antibodies, and mass spectrometry.

## Further Reading

- Shen Y, Wei W, Zhou DX. *Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression*. Trends in plant science. 2015. [PubMed 26440431](https://doi.org/10.1016/j.tplants.2015.07.005)
- Seto E, Yoshida M. *Erasers of histone acetylation: the histone deacetylase enzymes*. Cold Spring Harbor perspectives in biology. 2014. [PubMed 24691964](https://doi.org/10.1101/cshperspect.a018713)
- He W, Li Q, Li X. *Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer*. Biochimica et biophysica acta. Reviews on cancer. 2023. [PubMed 36403921](https://doi.org/10.1016/j.bbcan.2022.188837)
- Bradshaw PC. *Acetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan*. Antioxidants (Basel, Switzerland). 2021. [PubMed 33917812](https://doi.org/10.3390/antiox10040572)
- Liu X et al. *Histone Acetylation and Plant Development*. The Enzymes. 2016. [PubMed 27776781](https://doi.org/10.1016/bs.enz.2016.08.001)
- Yasui W et al. *Histone acetylation and gastrointestinal carcinogenesis*. Annals of the New York Academy of Sciences. 2003. [PubMed 12724227](https://doi.org/10.1111/j.1749-6632.2003.tb05977.x)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)